| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:07:56 UTC |
|---|
| Update date | 2019-11-26 03:02:07 UTC |
|---|
| Primary ID | FDB008114 |
|---|
| Secondary Accession Numbers | |
|---|
| Chemical Information |
|---|
| FooDB Name | Malic acid |
|---|
| Description | Mainly used as an acidifier in a wide range of food, such as fruit drinks, jams, sweet and sour sauces, boiled sweets, chewing gum. Occasionally used as a metal ion chelator in wine or in hard water. Flavour enhancer
Malic acid is the active ingredient in many sour or tart foods. Malic acid is found mostly in unripe fruits. Malic acid has two stereoisomeric forms (L- and D-enantiomers), though only the L-isomer exists naturally. Malic acid is found in many foods, some of which are garden rhubarb, sour cherry, white lupine, and coconut. |
|---|
| CAS Number | 6915-15-7 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 2-Hydroxybutanedioic acid | ChEBI | | 2-Hydroxyethane-1,2-dicarboxylic acid | ChEBI | | 2-Hydroxysuccinic acid | ChEBI | | alpha-Hydroxysuccinic acid | ChEBI | | Aepfelsaeure | ChEBI | | Apple acid | ChEBI | | DL-Malic acid | ChEBI | | e296 | ChEBI | | H2Mal | ChEBI | | Hydroxybutanedioic acid | ChEBI | | Hydroxysuccinic acid | ChEBI | | Malate | Kegg | | 2-Hydroxybutanedioate | Generator | | 2-Hydroxyethane-1,2-dicarboxylate | Generator | | 2-Hydroxysuccinate | Generator | | a-Hydroxysuccinate | Generator | | a-Hydroxysuccinic acid | Generator | | alpha-Hydroxysuccinate | Generator | | Α-hydroxysuccinate | Generator | | Α-hydroxysuccinic acid | Generator | | DL-Malate | Generator | | Hydroxybutanedioate | Generator | | Hydroxysuccinate | Generator | | Deoxytetrarate | HMDB | | Deoxytetraric acid | HMDB | | Musashi-NO-ringosan | HMDB | | Pomalus acid | HMDB | | R,S-Malate | HMDB | | R,S-Malic acid | HMDB | | R,SMalate | HMDB | | R,SMalic acid | HMDB | | Malic acid, disodium salt | HMDB | | Malic acid, disodium salt, (R)-isomer | HMDB | | Malic acid, disodium salt, (S)-isomer | HMDB | | Malic acid, monopotassium salt, (+-)-isomer | HMDB | | Malic acid, (R)-isomer | HMDB | | Malic acid, calcium salt, (1:1), (S)-isomer | HMDB | | Malic acid, magnesium salt (2:1) | HMDB | | Calcium (hydroxy-1-malate) hexahydrate | HMDB | | Malic acid, potassium salt, (R)-isomer | HMDB | | Malic acid, sodium salt, (+-)-isomer | HMDB | | 2-Hydroxydicarboxylic acid | biospider | | Butanedioic acid, 2-hydroxy- | biospider | | Butanedioic acid, hydroxy- | biospider | | E296 | db_source | | Hydroxy succinic acid | biospider | | Hydroxyethane-1,2-dicarboxylic acid | biospider | | Succinic acid, hydroxy- | biospider | | α-hydroxysuccinate | Generator | | α-hydroxysuccinic acid | Generator |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C4H6O5 |
|---|
| IUPAC name | 2-hydroxybutanedioic acid |
|---|
| InChI Identifier | InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9) |
|---|
| InChI Key | BJEPYKJPYRNKOW-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | OC(CC(O)=O)C(O)=O |
|---|
| Average Molecular Weight | 134.0874 |
|---|
| Monoisotopic Molecular Weight | 134.021523302 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Hydroxy acids and derivatives |
|---|
| Sub Class | Beta hydroxy acids and derivatives |
|---|
| Direct Parent | Beta hydroxy acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Short-chain hydroxy acid
- Beta-hydroxy acid
- Fatty acid
- Dicarboxylic acid or derivatives
- Alpha-hydroxy acid
- Secondary alcohol
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Industrial application: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 35.83%; H 4.51%; O 59.66% | DFC |
|---|
| Melting Point | 131-133 oC | |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | 1000 mg/mL at 20 oC | YALKOWSKY,SH & DANNENFELSER,RM (1992) |
|---|
| Experimental logP | -1.26 | HANSCH,C ET AL. (1995) |
|---|
| Experimental pKa | 3.4 | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-0076-9000000000-ad60ea592282d09e4bd8 | 2015-03-01 | View Spectrum | | GC-MS | Maslic acid, non-derivatized, GC-MS Spectrum | splash10-0002-0920000000-d3afa3ad5c227740eae3 | Spectrum | | GC-MS | Maslic acid, 3 TMS, GC-MS Spectrum | splash10-001i-0951000000-1d993823fa816ba3cfb1 | Spectrum | | GC-MS | Maslic acid, non-derivatized, GC-MS Spectrum | splash10-0002-0930000000-6a116527910d172eb561 | Spectrum | | GC-MS | Maslic acid, non-derivatized, GC-MS Spectrum | splash10-0002-0920000000-d3afa3ad5c227740eae3 | Spectrum | | GC-MS | Maslic acid, non-derivatized, GC-MS Spectrum | splash10-001i-0951000000-1d993823fa816ba3cfb1 | Spectrum | | Predicted GC-MS | Maslic acid, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0006-9100000000-aba7652c885a434930ef | Spectrum | | Predicted GC-MS | Maslic acid, 3 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-02j9-7191000000-b78c78194b39deee0ca4 | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Negative (Annotated) | splash10-03e9-3900000000-6112a756a8c8c7c7cd50 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Negative (Annotated) | splash10-00di-9100000000-b3efe8bce2f89afcff34 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Negative (Annotated) | splash10-00ec-9300000000-c0aaa5301dcac30685db | 2012-07-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00kr-7900000000-2a07c36db6acea9015af | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00rj-9200000000-316c7803efd1dfb76523 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-00dl-9000000000-a442bcaaacb6f4eec14d | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001r-9800000000-03bfaee5de56f72ed927 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0079-9200000000-26a075efe73adc63a189 | 2017-07-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-059f-9000000000-a3281a79477ac14e2eae | 2017-07-26 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 90 MHz, D2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 25.16 MHz, D2O, experimental) | | Spectrum | | 2D NMR | [1H, 1H]-TOCSY 2D NMR Spectrum (experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 510 |
|---|
| ChEMBL ID | CHEMBL1455497 |
|---|
| KEGG Compound ID | C03668 |
|---|
| Pubchem Compound ID | 525 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 6650 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB00744 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | DCG74-V:DCG74-V |
|---|
| EAFUS ID | 2097 |
|---|
| Dr. Duke ID | MALIC-ACID |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Malic_acid |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti-atherosclerotic | 38070 | An agent that prevents or slows the formation of atherosclerosis, a condition characterized by plaque buildup in arteries. It reduces inflammation, improves lipid profiles, and inhibits platelet aggregation, commonly used to manage cardiovascular diseases, such as coronary artery disease, and prevent heart attacks and strokes. | DUKE | | Anti bacterial | 33282 | An agent that inhibits the growth of or destroys bacteria, playing a crucial role in preventing and treating infections. Therapeutically, it is used to combat bacterial infections, with key medical applications including treating pneumonia, tuberculosis, and skin infections, as well as preventing surgical site infections and sepsis. | DUKE | | Anti-fibromyalgic | 52217 | An agent that alleviates symptoms of fibromyalgia, reducing pain, fatigue, and inflammation. It plays a biological role in modulating neurotransmitter activity and immune response. Therapeutically, it's used to manage fibromyalgia, chronic pain, and fatigue, improving quality of life for patients with these conditions. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti-seborrheic | 52217 | An agent that reduces seborrheic dermatitis symptoms, commonly used in managing scalp and skin conditions, such as dandruff, itching, and flaking, by inhibiting fungal growth and inflammation. | DUKE | | Anti septic | 33281 | An agent that prevents or reduces the growth of microorganisms, such as bacteria, fungi, or viruses, to promote wound healing and prevent infection. Therapeutically, anti septics are used to treat minor cuts, scrapes, and burns, and are commonly applied topically to reduce the risk of infection and promote tissue repair. Key medical uses include wound care, surgical site preparation, and skin infection management. | DUKE | | Anti-tubercular | 33282 | An agent that combats tuberculosis, playing a biological role in inhibiting the growth of Mycobacterium tuberculosis. Therapeutically, it is used to treat and prevent tuberculosis, with key medical applications including the treatment of active TB, latent TB, and TB meningitis, as well as preventing the spread of TB in high-risk populations. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Bacteristat | 33282 | An agent that inhibits bacterial growth, reducing the proliferation of microorganisms without killing them. Therapeutically, bacteristats are used to treat infections, preventing the spread of bacteria and allowing the host's immune system to clear the infection. Key medical uses include treating urinary tract infections, acne, and other bacterial infections where bactericidal agents may not be necessary. | DUKE | | Bruchiphobe | | An agent that counteracts Brucella bacteria, reducing infection risk. Therapeutically, it's used to prevent and treat brucellosis, a zoonotic disease. Key medical uses include prophylaxis and treatment of brucellosis in high-risk individuals, such as veterinarians and laboratory workers. | DUKE | | Hemopoietic | | An agent that stimulates the production of red blood cells, playing a crucial role in treating anemia, blood disorders, and supporting cancer patients undergoing chemotherapy, with key medical uses including increasing red blood cell count and improving oxygen delivery to tissues. | DUKE | | Laxative | 50503 | An agent that stimulates bowel movements, relieving constipation by softening stool or increasing intestinal motility. Therapeutically, laxatives are used to treat constipation, prepare the bowel for medical procedures, and manage certain medical conditions, such as irritable bowel syndrome. | DUKE | | Mycobactericide | | An agent that kills bacteria of the genus Mycobacteria, playing a crucial role in treating mycobacterial infections. Therapeutically, it is used to combat tuberculosis, leprosy, and other related diseases, serving as a key medical tool in controlling and eliminating these infections. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Sialogogue | | An agent that stimulates the flow of saliva, aiding digestion and oral health. Therapeutically, it helps manage dry mouth, protects teeth, and facilitates swallowing. Key medical uses include treating xerostomia, Sj�gren's syndrome, and radiation-induced salivary gland damage. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|